Mirapex - MSN Newsfeeds

Efficacy Of Boehringer Ingelheim's Pramipexole (Mirapexin®/Sifrol ...
Medical News Today - Pramipexole (known in Europe under the trade names Mirapexin® and Sifrol® and in the U.S.A. as Mirapex®) is a compound from Boehringer Ingelheim research first approved in 1997 for the treatment of the signs and symptoms of idiopathic Parkinson's ...
Police: Mother on drugs found with baby on road
Portsmouth Herald - Police said they searched her pocketbook and found two Mirapex pills, which are used for symptoms of restless leg syndrome. Szczuka was transported to Exeter Hospital for treatment and later taken back to the police station and held on $500 cash bail ...
12 Million Can't Sleep, Can't Sit With Restless Legs Syndrome
ABC News - She is now being treated with Mirapex, a dopamine agonist like Requip that has cured -- at least temporarily -- all her symptoms. "For the first time, I slept," Cardinale said. "I cried on the phone to the doctor, 'Thank you so much.' It's a miracle
Mother charged after police find baby with stranger
Newburyport Daily News - Mendes took Szczuka to Exeter Hospital for treatment after a search of her purse revealed two Mirapex pills, which treat restless legs syndrome. At Exeter, Szczuka was revived. It was then she told Mendes the amount and number of drugs she consumed ...
Taming the Tingles: Treatment for Restless Legs Syndrome
HealthCentral.com - Pramipexole, usually sold under the brand name Mirapex, is a new dopamine receptor agonist, a drug that binds to and activates dopamine receptors. Dopamine receptors are Cell-surface proteins that bind dopamine with high affinity and trigger ...
FDA: Parkinson's Drug Pulled from Market
WXYZ - Other dopamine agonists include GlaxoSmithKline's Requip, or ropinirole, and Boehringer Ingelheim Pharmaceuticals, Inc.'s Mirapex, or pramipexole. Shares of Valeant closed up 2 cents at $17.13 on the New York Stock Exchange on Thursday. Shares of Par ...
MSU, U-M selected to participate in national Parkinson's disease study
Detroit News - Eligible patients must have a confirmed case of the disease and take medications such as Sinemet, Requip or Mirapex, for at least nine months but no longer than two years, according to MSU. Investigators will measure disease progression by measuring ...
12 Million Can't Sleep, Can't Sit With Restless Legs Syndrome
ABC News - Sensations are often described as burning, creeping, tugging, or like insects crawling inside the legs. Doctors are now saying heavily advertized drugs like Requip and Mirapex can make symptoms even worse. They recommend rotating those drugs with ...
Readers share their experiences with tonic water
Biloxi Sun Herald - Prescription drugs approved to treat this condition include ropinirole (Requip) and pramipexole (Mirapex), agents that enhance the activity of the neurotransmitter dopamine. Drug side effects can include nausea and vomiting, dizziness, drowsiness or ...
12 Million Can't Sleep, Can't Sit With Restless Legs Syndrome
ABC News - Sensations are often described as burning, creeping, tugging, or like insects crawling inside the legs. Doctors are now saying heavily advertized drugs like Requip and Mirapex can make symptoms even worse. They recommend rotating those drugs with ...
Parkinson's Patch Nears U.S. Approval
CBS News - The two currently leading dopamine agonists, Mirapex and Requip, are oral drugs that are shown to do that." Unfortunately, patients on these drugs may begin to experience the on/off effect as well. It's been thought that this happens because oral ...
Parkinson's Patch Nears U.S. Approval
FOX News - The two currently leading dopamine agonists, Mirapex and Requip, are oral drugs that are shown to do that." Unfortunately, patients on these drugs may begin to experience the on/off effect as well. It's been thought that this happens because oral ...
Tweaking the Treatment for Restless Legs
innovations report - In the wake of FDA approval for Requip and Mirapex (pramipexole), along with the attendant heavy advertising, Kurlan and Richard stress the importance to both primary care physicians and patients alike of understanding the risks of relying on these ...
Parkinson's Disease: Diagnosis and Treatment
American Family Physician - Pramipexole (Mirapex), Ropinirole (Requip) Nausea, sleep attacks, edema, hallucinations, hypotension Useful for early disease and in patients with Parkinson's disease and motor fluctuations MAO-B inhibitors Selegiline (Eldepryl) ...
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary ...
PR Newswire - RIDGEFIELD, Conn., Nov. 10 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex(R) (pramipexole dihydrochloride) tablets for the treatment of moderate-to ...
Latest Data Demonstrate Boehringer Ingelheim's Pramipexole (Mirapexin ...
Medical News Today - Pramipexole (known in Europe under the trade names Sifrol® and Mirapexin® and in the U.S.A. as Mirapex®) is a compound from Boehringer Ingelheim research first licenced in 1997 for the treatment of the signs and symptoms of idiopathic Parkinson`s ...
Boehringer Ingelheim’s Pramipexole (Mirapexin/Sifrol) Shown to ...
Phramalive.com - Pramipexole (known in Europe under the trade names Sifrol® and Mirapexin® and in the U.S.A. as Mirapex®) is a compound from Boehringer Ingelheim research first licensed in 1997 for the treatment of the signs and symptoms of idiopathic Parkinson`s ...
Latest Data Demonstrate Boehringer Ingelheim’s Pramipexole ...
Phramalive.com - Pramipexole (known in Europe under the trade names Sifrol® and Mirapexin® and in the U.S.A. as Mirapex®) is a compound from Boehringer Ingelheim research first licenced in 1997 for the treatment of the signs and symptoms of idiopathic Parkinson`s ...
Analysis: Schwarz drug to top RLS market
United Press International - Boehringer Ingelheim's Mirapex will lead the pack for a while, but it's also facing generic erosion in 2011 when its patent expires. That will open the doors for Schwarz, XenoPort and Serono. Schwarz's rotigotine CDS, which is expected to launch in ...
Chatological Humor* aka Tuesdays With Moron
Washington Post - When I was originally diagnosed I was put on another dopamine agonist, Mirapex, which worked well for about a month or so, then I had to increase the dosage to continue to get the benefits. And that would happen every couple of months. I increased to ...

Pages:   1   2   Next

AddThis Social Bookmark Button

Need A Mirapex Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Need A Mirapex Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Mirapex Case - Submit Your Information Below

Do you need legal assistance with your Mirapex case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Mirapex Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.